New lipid-lowering drugs: an update von Wierzbicki, A. S., Hardman, T. C., Viljoen, A.

Volltext

Erythrocyte sodium-lithium countertransport in African American women von HARDMAN, T. C, WIERZBICKI, A. S

Volltext

Controversies surrounding erythrocyte sodium-lithium countertransport von Hardman, Timothy C, Lant, Ariel F

Volltext

Pharmacokinetics and safety of escalating single and repeat oral doses of GW420867X, a novel non-nucleoside reverse transcriptase inhibitor von MOORE, K. H. P, CASS, L. M, DALLOW, N, HARDMAN, T. C, JONES, A, BOYCE, M, PRINCE, W. T

Volltext

Sodium-Lithium Countertransport Activity Is Linked to Chromosome 5 in Baboons von Hardman, Timothy C, Noble, Mark I.M

Volltext

Transport of phytanic acid on lipoproteins in Refsum disease von Wierzbicki, A. S., Sankaralingam, A., Lumb, P. J., Hardman, T. C., Sidey, M. C., Gibberd, F. B.

Volltext

Kinetic characteristics of the erythrocyte sodium-lithium countertransporter in black normotensive subjects compared with three other ethnic groups von HARDMAN, T. C, CROFT, P, MORRISH, Z, ANTO-AWOAKYE, K, LANT, A. F

Volltext

Effects of lipids in patients with familial hypercholesterolaemia on the kinetics of the sodium-lithium countertransporter von WIERZBICKI, A. S, HARDMAN, T. C, CHEUNG, J, LAMBERT-HAMMILL, M, PATEL, S, MORRISH, Z, LUMB, P. J, LANT, A. F

Volltext

Urinary retinol-binding protein (RBP) excretion and erythrocyte sodium-lithium countertransport (SLC) activity in a cohort of healthy normotensive subjects von HARDMAN, T. C, DUBREY, S. W, SONI, S, CLIFFORD, R, CHALKLEY, S, WIERZBICKI, A. S

Volltext

Na,Li-countertransport and ethnicity von Hardman, T.C., Wierzbicki, A.

Volltext

Enhanced activity of sodium-lithium countertransport in patients with cardiac syndrome X: a potential link between cardiac and metabolic syndrome X von Hardman, T C, Clifford, R H, Dubrey, S W

Volltext

Pharmacokinetics and Tolerability of GW420867X, a Nonnucleoside Reverse Transcriptase Inhibitor, following Single Escalating Doses in Healthy Male Volunteers von Moore, Katy H. P., Cass, Lindsey M., Dallow, Nigel, Hardman, Timothy C., Jones, Anne, Boyce, Malcolm, Prince, William T.

Volltext

Influence of plasma phytanic acid levels in Refsum's disease on the behaviour of the erythrocyte membrane sodium-lithium countertransporter von WIERZBICKI, A. S, HARDMAN, T. C, LUMB, P, SANKARALINGAM, A, MORRISH, Z, PATEL, F, SIDEY, M. C, GIBBERD, F. B

Volltext

Characterization of the erythrocyte sodium-lithium countertransporter: limitations and assumptions of traditional and kinetic methodologies von Hardman, T C, Thomas, T, Lant, A F

Volltext

Kinetic characteristics of the erythrocyte sodium-lithium countertransporter in subjects with coronary artery disease von Hardman, Timothy C., Barlow, Richard, Dubrey, Simon W., Croft, Paula, Lant, Ariel F.

Volltext

Kinetic behavior of the erythrocyte sodium-lithium countertransporter in nonnephropathic diabetic twins von Hardman, Timothy C., Dubrey, Simon W., Leslie, R.David G., Lant, Ariel F.

Volltext

The current status of antihypertensive treatments: into the new millennium von Hardman, Timothy C, Lunnon, Martin W

Volltext

New lipid-lowering drugs: an update: New lipid drugs von Wierzbicki, A. S., Hardman, T. C., Viljoen, A.

Volltext

Relation between sodium–lithium countertransport and hypertriglyceridemia in type V hyperlipidemia von Wierzbicki, Anthony S, Hardman, Timothy C, Cheung, Joseph, Patel, Mayur, Smallberger, Sarah, Lumb, Peter J, Lant, Ariel F

Volltext

Erythrocyte sodium-lithium countertransport and blood pressure in identical twin pairs discordant for insulin dependent diabetes von Hardman, T. C., Dubrey, S. W., Leslie, D. G., Hafiz, M., Noble, M. I., Lant, A. F.

Volltext